James Green
Translating the complexity of a world in motion into the intelligence you need.
About This Column
James Green is a writer and strategist dedicated to finding the "signal in the noise" of modern progress. Building on a career spent deconstructing the high-stakes world of biotech and medical innovation, James now applies his forensic curiosity to the broader forces of change. He specializes in translating complex technological, market, and social shifts into clear, actionable insights. Whether he is analyzing a disruptive new industry, a shift in global investment, or the future of infrastructure, James provides the critical context needed to understand how today’s breakthroughs will reshape our world tomorrow.
Displaying items 501-520 of 525 in total
The Everything Wallet: Kickstarter Darling or Over-Engineered Gadget?
New Far-UVC Light Tech Neutralizes H5N1, Bolstering Food Security
CytomX Spotlight: Can Masked Biologics Unmask Investor Value?
Teva Enters Europe's $1.2B Bone Drug Market with Biosimilar Approvals
MSIG's Cyber Gambit: New Chief to Tackle Volatile Digital Risk Market
Tempest Therapeutics Secures Lifeline Funding Amid Strategic Pivot
The Seaweed Solution: How Alginate is Driving Medical Innovation
Hexaware's German Debut: A New Blueprint for IT Sourcing Value
AI Scribes Slash Admin Time, Offering a Lifeline for Mental Health Care
USVI Wields $24B Rebuild to Pressure Caribbean 'Golden Passport' Nations
The Sophistication Shift: AI Arms Race Redefines Digital Fraud
Rocket Lab & JAXA Pact: A Strategic Lift for Small Satellite Market
Beyond the Blueprint: How Integrated Design Drives Business Growth
Canada's 'Painted Forest' Sets New Standard for Carbon Credits
Europe's Car Wash Boom: How Data is Fueling a $4.3B Industry
Manitoba's $2M Bet on Virtual Care for Francophone Patients
AI Nears FDA Submission After 99.5% Heart Failure Detection at Mayo Clinic
Beyond Chatbots: GenAI Now Negotiates Deals and Runs Mines
Biodexa Launches EU Trial for First Pill to Prevent Genetic Cancer
